HELP     Sign In

19q12-q13.11CNV Type: Duplication


Largest CNV size: 2463866 bp

Statistics Box:
Number of Reports: 4



Summary Information

A de novo duplication spanning this region was identified in a patient from the Deciphering Developmental Disorder (DDD) study that presented with global developmental delay and dysmorphic features (Fitzgerald et al., 2014).

Additional Locus Information

Genome browsers

USCS Symbol             NCBI Symbol

Decipher

            Decipher Symbol

References

Major Reports

Title
Author, Year
Report Class
CNV Type

No Major Reports

Minor Reports

Title
Author, Year
Report Class
CNV Type
Large-scale discovery of novel genetic causes of developmental disorders.
Duplication
TSHZ3 deletion causes an autism syndrome and defects in cortical projection neurons.
Deletion
Prevalence and phenotypic impact of rare potentially damaging variants in autism spectrum disorder
Deletion
Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses
Deletion

Cases

Cohort ID
Author, Year
Descripton
Cohort Size
Diagnosis
Age
Gender
CNV Size
Deletion
Duplication
Total CNV's
 caubit_16_ASD/ID_discovery_cases
 Seven patients from six unrelated families with 19q12-q13.11 deletions that included the TSHZ3 gene but not the 19q13.11 syndrome critical region
 7
 5/7 cases present with ASD
 N/A
 57.14% Male
 4020000
 2
 0
 2
 fitzgerald_14_ASD/DD/ID_discovery_cases
 Children recruited through all 24 regional genetics services of the UK National Health Service and Republic of Ireland as part of the Deciphering Developmental Disorders Study
 1133
 Cases affected by severe, undiagnosed developmental disorders; most common phenotypes include developmental delay, intellectual disability, specific learning disability, autism, seizures, microcephaly, and dysmorphic features.
 Median age, 5.5 years
 N/A
 2463866
 0
 1
 1
 laurie_25_ASD/DD/ID_discovery_cases
 Individuals with previously undiagnosed rare diseases from 6,004 families from the Solve-Rare Diseases Consortium (Solve-RD) resource for whom systemic reanalysis of exome or genome sequencing data was performed and phenotypic information was annotated using the Human Phenotype Ontology.
 6447
 "Individuals with autism or autistic features as defined by one or more of the following HPO terms: ""Autism"", ""Autistic behavior"", ""Stereotypy"", or ""Recurrent hand flapping""."
 
 55.71% Male
 3335297
 1
 0
 1
 mahjani_21_ASD_discovery_cases
 Study participants in the PAGES cohort, a large ongoing population-based cohort study in Sweden that started in 2012 with the overall aim to identify possible genetic and environmental risk factors for ASD.
 996
 Cases diagnosed with ASD according to ICD-9 and ICD-10 criteria.
 Average age at diagnosis, 8.2 yrs.
 70% Male
 4933712
 1
 0
 1

Controls

No Control Data Available

Cases

Cohort ID
Geographical Ancestry
Discovery Method
Platform
Algorithm
Software
Validation Method
 caubit_16_ASD/ID_discovery_cases
  N/A
 N/A
  Discovery platform N/A
 
 
 Not reported
 fitzgerald_14_ASD/DD/ID_discovery_cases
  UK and Ireland
 aCGH, WES
  Agilent 2x1M, Agilent Exome+
 
 Cnsolidate, CoNVex
 None
 laurie_25_ASD/DD/ID_discovery_cases
  European
 Exome sequencing, genome sequencing
 
 
 ClinCNV, Conifer, ExomeDepth
 
 mahjani_21_ASD_discovery_cases
  Sweden
 WES
  Infinium OmniExpress Exome
 PennCNV
 NA
 None

Controls

No Control Data Available

Cases

Patient ID
Author, Year
Age
Gender
Primary Diagnosis
Clinical Profile
Cognitive Profile
CNV Start
CNV End
CNV Size
Genome Build
Type Method
Validation
  caubit_16_ASD/ID_discovery_cases-case2
 N/A
 M
 ASD and intellectual disability
 Developmental milestones:. Lanaguge and communication evaluation: absent speech. Behavioral/psychiatric evaluation: ASD. Epilepsy/seizures: seizures that required antiepileptic drugs. Additional medical history: nephrolithiasis.
 Intellectual disability
 N/A
 N/A
  4020000
 GRCh37
 Deletion
 No
  caubit_16_ASD/ID_discovery_cases-case5
 N/A
 M
 Intellectual disability
 Developmental milestones: speech delay. Behavioral/psychiatric evaluation: hyperactivity, social behavioral disinhbition, graphic difficulties. Dysmorphic features: aplasia cutis in midline of scalp.
 Intellectual disability
 N/A
 N/A
  2870000
 GRCh37
 Deletion
 No
  fitzgerald_14_ASD/DD/ID_discovery_cases-DECIPHER263549
 N/A
 F
 Developmental delay
 Broad lateral eyebrow; Deeply set eye; Upslanted palpebral fissure; Epicanthus; Wide nose; Downturned corners of mouth; Thick lower lip vermilion; Abnormality of tear glands or tear production; Drooling; High palate; Hyperpigmentation of the skin; Inverted nipples; Increased body weight; Short tapering fingers; Impaired pain sensation; Global developmental delay
 
 29888973
 32352840
  2463868
 GRCh38
 Duplication
 No
  laurie_25_ASD/DD/ID_discovery_cases-caseP0013051
 
 M
 Developmental delay, intellectual disability, specific learning disability, and autistic behavior
 Cryptorchidism/Abnormality of the dentition/Epicanthus/Protruding ear/Upslanted palpebral fissure/Autistic behavior/Delayed speech and language development/Soft skin/Intellectual disability/Motor delay/Specific learning disability/Neonatal hyperbilirubinemia/Clinodactyly of the 5th finger/Short stature/Decreased body weight/Feeding difficulties in infancy/Dilatation of the renal pelvis
 
 29076155
 32411451
  3335297
 GRCh38
 Deletion
 No
  mahjani_21_ASD_discovery_cases-case222
 NA
 M
 ASD
 Diagnosis of ASD according to ICD-9 and ICD-10 criteria.
 
 28113797
 33047508
  4933712
 GRCh38
 Deletion
 No

Controls

No Control Data Available

Cases

Patient ID
Validation Description
Primary Disorder Inheritence
Inheritence
Family Profile
Disease Segregation
Gene Content
Altered Gene Expression
 caubit_16_ASD/ID_discovery_cases-case2
 None reported
 
 De novo
 
 Likely segregated
 CNV gene content N/A due to lack of defined start and end points but does contain at least part of the TSHZ3 gene (minimal region of overlap of chr19:31765881-31812396; hg19)
 
 caubit_16_ASD/ID_discovery_cases-case5
 None reported
 
 De novo
 
 Likely segregated
 CNV gene content N/A due to lack of defined start and end points but does contain at least part of the TSHZ3 gene (minimal region of overlap of chr19:31765881-31812396; hg19)
 
 fitzgerald_14_ASD/DD/ID_discovery_cases-DECIPHER263549
 
 
 De novo
 Simplex
 Segregated
 PPIAP58,RPL9P32,TAF9P3,LINC01834,RNA5SP471,RNU6-967P,LINC01782,RNA5SP472,LINC01533,URI1,LINC01791,TSHZ3,LINC01837,ZNF507,ZNF536
 
 laurie_25_ASD/DD/ID_discovery_cases-caseP0013051
 
 
 Unknown
 Simplex
 
 CCNE1,TSHZ3,PLEKHF1,C19orf12,PPIAP58,DPY19L3,TAF9P3,VSTM2B-DT,VSTM2B,DPY19L3-DT,RPL9P32,RNA5SP471,RNA5SP472,LINC01533,LINC01782,UQCRFS1-DT,LINC01837,LINC02841,UQCRFS1,RNU6-967P,RN7SL340P,LINC01791,LINC01834,TSHZ3-AS1,URI1,ZNF536,POP4,ZNF507
 
 mahjani_21_ASD_discovery_cases-case222
 
 
 Unknown
 
 
 CCNE1,TSHZ3,PLEKHF1,C19orf12,ANKRD27,RHPN2,FAAP24,CEP89,TDRD12,PPIAP58,DPY19L3,LINC00906,TAF9P3,VSTM2B-DT,VSTM2B,RGS9BP,DPY19L3-DT,NUDT19,RPL9P32,RPS12P31,MAN1A2P1,RPL31P60,LINC01532,LINC01533,RNA5SP470,RNA5SP472,RNA5SP471,LINC01782,LINC01837,UQCRFS1-DT,LINC02841,UQCRFS1,RNU6-967P,RN7SL789P,RN7SL340P,RN7SKP22,LINC01791,TSHZ3-AS1,LINC01834,SNORA68B,URI1,NUDT19-DT,ZNF536,PDCD5,ZNF507,POP4,SLC7A9
 

Controls

No Control Data Available
No Animal Model Data Available
HELP
Copyright © 2017 MindSpec, Inc.